Bone Health… Life Wealth

The Company: Nikken, Inc. (Nihon Kenko Zoushin Kenkyukai)

  • Founded in 1975 - Fukuoka, Japan. World Headquarters - Irvine, Calif., USA
  • Research, Development, and Distribution of cutting-edge, proprietary technologies developed by top researchers and scientists. The technologies are brought to market via Independent Wellness Consultants who have partnered with Nikken.
  • High tech yet natural technologies in the areas of sleep, exercise, hydration, pH balance, air treatment, skin & nutrition.
  • Debt Free. Global Presence. 5-A1 Dunn & Bradstreet rating.
  • 5 Pillars Philosophy: Balance in Healthy Mind, Body, Family, Society, Finances.

A New Breakthrough Technology: OsteoDenx

  • Provides a transport system for replenishment of bone… Not a vitamin supplement.
  • Not a chemical drug. No negative side effects. Contains no calcium.
  • Provides an anti-aging and for some, a reverse-aging effect to the bone.
  • Severe osteoporosis cases: double-digit increased bone density is possible in one year.
  • Properly functioning bones bring other vital systems into balance.
  • Bones (which create red/white blood cells) are fundamental to the immune system.

The Clinical Trials:

  • Pre-clinical trial in 2007. View at
  • 1st trial (Osteoporosis International; 2009Jan27) shows how Ribonuclease Enriched Lactoferrin (RELF), market name: OsteoDenx, promotes the formation of new capillaries and new bone.
  • The 2nd trial targeting the inflammatory mediators having to do with Osteoarthritis, Rheumatoid Arthritis and Osteopenia. Results TBA early ’09.
  • The 3rd trial showing how RELF effects bone turnover indiabetics. TBA mid ’09.
  • The 4th study showing how RELF effects bone turnover in young adults withobesity.
  • The 5th study showing RELF effects on bone turnover inHIV patients. TBA late ’09.

The Genius: Dr. Narain Naidu, Ph.D.

  • His discoveries are the basis for the founding of 4 successful Biotech companies.
  • On Faculty of Universities in Europe, Asia and the United States.
  • Consults Government Health Agencies, Pharmaceutical and Biotech enterprises worldwide.
  • 100 research publications, 25 book chapters, and 2 best selling reference volumes.
  • Solved toxic shock syndrome and the e-coli problem in the US beef industry.
  • Director: Center for Antimicrobial Research.
  • Medical Microbiologist: California State Polytech University.
  • Director (Past)
  • On the short list for: Nobel Prize.

The Current Solution:

  • Prescription drugs: designed to inhibit calcium from exiting bones - leaving other bodily systems that require calcium (from bones) to suffer.
  • Bones may become denser but are weaker. Natural bone turnover process is inhibited. Some of the medications may even create a brittle bone matrix.
  • Side effects:esophageal cancer,altered taste, mental irritability, numbness, seizures, dental problems (including deteriorating jaw bones), anemia, blood clotting disorders, decreased joint mobility, pain in the muscles, joints and or bones, eye problems, skin rash, gastrointestinal abnormalities, inflammation of the esophagus, chest pain, heartburn or difficulty swallowing… (and that’s what we’re aware of.)
  • Calcium supplementation: Studies indicate, “the excess calcium buries itself in your artery walls and muscle cells where it contributes to high blood pressure and hardening of the arteries. Why do you think doctors give you calcium channel blockers for high blood pressure?” [NewsMax]

The Osteodenx Solution:

  • Targets the synovial fluid using a Syno-Portin complex unique to Osteodenx,
  • Bone metabolism: reestablishesan efficient system as in your youth.
  • When our bones function properly other systems can recalibrate.
  • 3 Components: OsteoDenx,Nikken Calcium Plus, Lactoferrin Gold 1.8.
  • Nikken Inc. and its Consultants hold exclusive distribution rights.
  • Osteodenx technology is protected by 2 patents plus three patents pending.

The Market:

  • 10 Million Americans have Osteoporosis.
  • 34 Million Americans have low bone mass.
  • 66 Million - joint related issues. TOTAL: 110 Million people affected.
  • Studies indicate our teenage youth are at risk for osteoporosis. Athletes, mothers, older men and women, and anyone seeking a wellness path are candidates.
  • “They will not fall and break their bones; they will break their bone…and fall.”
  • Fosamax sold $3 Billion in 2005. Bovina sold $417 Million in 2006.
  • Actonel: Proctor & Gamble’s biggest product to reach $1billion in sales.
  • Osteoporosis pharmaceutical market will reach $10.4 billion by 2011.

The Cost Comparison

  • One Prescription Actonel pill (150 mg) averages $100 or $400.00+ per month.
  • The OsteoDenx Solution:under half the cost and available without a prescription.

The Benefits of “Life Wealth” with OsteoDenx and Nikken Inc.

Fulfilling. Part or full time. Extra Income. Set your own schedule. More spare time. Chose who you work with. Meet new people. Low overhead. No employees. No Inventory. No shipping. No accounting. Work from home or Travel…Global opportunity. No territories. FUN! Set your own pace. Training and Support. Mentor with Millionaire Entrepreneurs. Leverage your Time and Effort. Create a Residual Income. Retirement. Leave a Legacy. Auto and Home Bonus. Personal Development. Powerful online tools. Expansion with access to a complete line of leading, proprietary, patented health technologies. Help others.